Needham Healthcare Conference

 
News Articles for Needham Healthcare Conference top ^
SALT LAKE CITY, April 4, 2014 (GLOBE NEWSWIRE) -- Amedica (Nasdaq:AMDA) announced today that it has been invited to present at the 13th Annual Needham Healthcare Conference, being held at the Westin Grand Central Hotel on April 8th and 9th in New York City.
Sign-up for Amedica to Present at the 13th Annual Needham Healthcare Conference investment picks
NORTHBROOK, Ill., April 3, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH) , a company enhancing medicine through targeted molecular diagnostics, today announced that that an overview of the Company's business and commercial strategy will be given at the 13 th Annual Needham Healthcare Conference, being held at the Westin Grand Central Hotel in New York City from April 8-9, 2014.
Sign-up for Nanosphere to Present at the 13th Annual Needham Healthcare Conference investment picks
NEWARK, Calif., March 19, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will present at the 13th Annual Needham Healthcare Conference, on Wednesday, April 9, at 8:40 AM EDT at the Westin Grand Central Hotel, 212 East 42nd Street, in New York City.
Sign-up for StemCells, Inc. to Participate at the 13th Annual Needham Healthcare Conference investment picks
SOUTH SAN FRANCISCO, Calif., April 1, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Aron Knickerbocker, Chief Business Officer, will present at the 13 th Annual Needham Healthcare Conference on April 8, 2014 at 4:20 PM Eastern Time.
Sign-up for Five Prime Therapeutics to Present at the 13th Annual Needham Healthcare Conference investment picks
WALTHAM, Mass., April 1, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that William Heiden, AMAG's chief executive officer, will present at the 13 th Annual Needham Healthcare Conference on Wednesday, April 9, 2014 at 2:20 p.m. ET in New York.
Sign-up for AMAG Pharmaceuticals, Inc. to Present at the Needham Healthcare Conference investment picks
BRISBANE, Calif., April 1, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the 13 th Annual Needham Healthcare Conference on Tuesday, April 8, 2014 at 10:00 a.m. ET.
Sign-up for Hyperion Therapeutics to Present at the 13th Annual Needham Healthcare Conference investment picks
ROCKVILLE, Md., April 1, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX) , a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, today announced that Jim Karrels, Vice President and Chief Financial Officer, and Eric Risser, Vice President of Business Development, will present at the 13 th Annual Needham Healthcare Conference.
Sign-up for MacroGenics to Present at the 13th Annual Needham Healthcare Conference investment picks
BURLINGTON, Mass., April 4, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the 13 th Annual Needham Healthcare Conference at the Westin Grand Central Hotel, New York, NY, on Wednesday, April 9, 2014.
Sign-up for LeMaitre Vascular to Present at the Needham Healthcare Conference on Wednesday, April 9, 2014 investment picks
SCHAUMBURG, Ill., April 2, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) , a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that it will present at the 13 th Annual Needham Healthcare Conference in New York on Wednesday, April 9, 2014 at 11:20 a.m. EDT.
Sign-up for Sagent Pharmaceuticals to Present at 13th Annual Needham Healthcare Conference investment picks
BURLINGTON, Mass., April 2, 2014 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that CEO Michael Clayman, M.D., will present an overview of the company at the 13th Annual Needham Healthcare Conference .
Sign-up for Flexion Therapeutics to Present at the 13th Annual Needham Healthcare Conference investment picks
WAYNE, Pa., April 2, 2014 (GLOBE NEWSWIRE) -- Egalet Corporation (Nasdaq:EGLT) ("Egalet") today announced that Bob Radie, president and chief executive officer, is scheduled to present next week at the 13 th Annual Needham Healthcare Conference on Wednesday, April 9, 2014, at 2:20 p.m. EDT.
Sign-up for Egalet to Present at the 13th Annual Needham Healthcare Conference on April 9 investment picks
LEXINGTON, Mass., April 2, 2014 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS) , an oncology-focused drug development company seeking to develop novel drug candidates for the treatment of human cancers, today announced that the Company will present at the 13 th Annual Needham Healthcare Conference at 1:40 p.m. ET on April 9, 2014, in New York City.
Sign-up for Curis to Present at the 13th Annual Needham Healthcare Conference investment picks
NATICK, Mass., April 8, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) , a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, announced today that Michael Kauffman, Chief Executive Officer, is scheduled to present a company overview at the 13 th Annual Needham Healthcare Conference.
Sign-up for Karyopharm Therapeutics to Present at 13th Annual Needham Healthcare Conference investment picks
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 13th Annual Needham Healthcare Conference on Tuesday, April 8, 2014 at 12:10 PM ET.
Sign-up for Stemline Therapeutics to Present at the 13th Annual Needham Healthcare Conference investment picks
SOUTH SAN FRANCISCO, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO) , a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections, announced today that it will present at the 13 th Annual Needham Healthcare Conference in New York, New York.
Sign-up for Achaogen to Present at 13th Annual Needham Healthcare Conference investment picks
2014/4/7
CALGARY , April 7, 2014 /PRNewswire/ - Dr.
Sign-up for Media Advisory - Oncolytics Biotech® Inc. to Participate in 13th Annual Needham Healthcare Conference investment picks
CRANBURY, N.J., March 27, 2014 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) , a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that John F.
Sign-up for Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference investment picks
MALVERN, Pa., March 31, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that J.
Sign-up for TetraLogic to Present at the 13th Annual Needham Healthcare Conference investment picks
PORTLAND, Ore., April 3, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE) , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J.
Sign-up for Galena Biopharma to Present at the 13th Annual Needham Healthcare Conference investment picks
GAITHERSBURG, Md., April 2, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) , a clinical-stage vaccine company, announced today that Stanley C.
Sign-up for Novavax to Present at the 13th Annual Needham Healthcare Conference investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Needham Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Natural Stock Funds  |  Next: Needham Research